In a patient with a TSH of 141 mIU/L and markedly low T3 and T4, how should levothyroxine tablets be initiated and titrated?

Levothyroxine Initiation in Severe Overt Hypothyroidism (TSH 141 mIU/L)

Start levothyroxine immediately at 1.6 mcg/kg/day for patients under 60 years without cardiac disease, or 25-50 mcg/day for elderly/cardiac patients, after ruling out adrenal insufficiency. 1, 2

---

Critical Safety Step Before Starting Treatment

Rule out concurrent adrenal insufficiency before initiating levothyroxine, as starting thyroid hormone before corticosteroids can precipitate life-threatening adrenal crisis. 1, 3

• Obtain morning (8 AM) serum cortisol and ACTH levels before starting therapy 1
• If adrenal insufficiency is present or suspected (especially in central hypothyroidism or hypophysitis), start physiologic dose steroids 1 week prior to levothyroxine 1, 3
• This is particularly critical in patients with autoimmune hypothyroidism (Hashimoto's), who have increased risk of concurrent autoimmune adrenal insufficiency 1

---

Initial Dosing Algorithm

For Patients Under 60 Years Without Cardiac Disease:

Start with full replacement dose of 1.6 mcg/kg/day (based on ideal body weight). 1, 2, 4

• This approach is safe in cardiac asymptomatic patients and reaches euthyroidism faster 4
• A prospective randomized trial demonstrated no cardiac events with full-dose initiation in cardiac asymptomatic patients 4
• Euthyroidism was achieved significantly faster with full-dose vs. low-dose initiation (13 vs. 1 patient at 4 weeks, p=0.005) 4

For Patients Over 60 Years OR With Cardiac Disease:

Start with 25-50 mcg/day and titrate gradually. 1, 2, 5

• Lower starting doses prevent unmasking cardiac ischemia or precipitating arrhythmias 1, 2
• Rapid normalization can worsen angina, precipitate myocardial infarction, or cause fatal arrhythmias 1
• Elderly patients with coronary disease are at increased risk of cardiac decompensation even with therapeutic doses 1

---

Dose Titration Protocol

Increase levothyroxine by 12.5-25 mcg increments every 6-8 weeks based on TSH response. 1, 2

• Use smaller increments (12.5 mcg) for elderly patients (>70 years) or those with cardiac disease 1
• Use larger increments (25 mcg) for younger patients without cardiac disease 1
• Wait 6-8 weeks between adjustments to reach steady state—adjusting too frequently is a common pitfall 1, 6
• The peak therapeutic effect may not be attained for 4-6 weeks 2

---

Monitoring Strategy

Initial Titration Phase:

Recheck TSH and free T4 every 6-8 weeks after each dose adjustment. 1, 2, 7

• Target TSH within reference range (0.5-4.5 mIU/L) with normal free T4 1, 2
• Free T4 helps interpret ongoing abnormal TSH levels during therapy, as TSH may take longer to normalize 1
• For patients with cardiac disease or atrial fibrillation, consider more frequent monitoring within 2 weeks 1

Maintenance Phase:

Once TSH is stable at goal, monitor TSH annually or sooner if symptoms change. 1, 7

• Approximately 25% of patients are unintentionally maintained on doses sufficient to fully suppress TSH, increasing serious complication risks 1, 8

---

Special Considerations for This Patient

With TSH 141 mIU/L and very low T3/T4, this represents severe overt hypothyroidism requiring immediate treatment. 7

Assess for Myxedema Coma Risk:

• Look for hypothermia, hypotension, altered mental status, hypoventilation 7
• If present, this requires ICU management with IV levothyroxine and has 30% mortality 7
• For IV dosing: use 50-75% of oral dose due to higher bioavailability 3

Cardiovascular Assessment:

• Hypothyroidism causes cardiac dysfunction including delayed relaxation, abnormal cardiac output, and increased systemic vascular resistance 1
• Untreated hypothyroidism increases risk for heart failure and cardiovascular events 7
• Treatment improves cardiac function and reduces cardiovascular risk 1

Check for Associated Conditions:

• Measure anti-TPO antibodies to confirm autoimmune etiology (Hashimoto's thyroiditis causes 85% of hypothyroidism in iodine-sufficient areas) 7
• Positive anti-TPO antibodies predict 4.3% annual progression risk vs. 2.6% in antibody-negative individuals 1
• Screen for other autoimmune conditions, particularly adrenal insufficiency 1
• Check lipid profile, as hypothyroidism adversely affects LDL cholesterol 1

---

Critical Pitfalls to Avoid

Never start at full replacement dose in elderly patients with cardiac disease—this can precipitate myocardial infarction, heart failure, or fatal arrhythmias. 1

Never start thyroid hormone before ruling out adrenal insufficiency—this can precipitate life-threatening adrenal crisis. 1, 3

Avoid excessive dose increases—jumping to full replacement risks iatrogenic hyperthyroidism with atrial fibrillation, osteoporosis, and cardiac complications. 1, 8

Do not adjust doses too frequently—wait 6-8 weeks between adjustments to reach steady state. 1, 6

Avoid overtreatment—even slight overdose carries significant risk of osteoporotic fractures and atrial fibrillation, especially in elderly and postmenopausal women. 1, 8, 6

---

Administration Instructions

Take levothyroxine on an empty stomach, 30-60 minutes before breakfast. 1, 8

• Separate from iron, calcium supplements, or antacids by at least 4 hours 1
• Consistent timing and fasting state are critical for absorption 1

---

Expected Outcomes

Symptoms should improve within 6-8 weeks of adequate replacement. 1

• Fatigue, weight gain, cold intolerance, and cognitive issues typically resolve 7
• Cardiovascular function improves and LDL cholesterol decreases 1
• Quality of life significantly improves with normalization of thyroid function 1